| | | | | | | |
 | VERTEX PHARMACEUTICALS | -3.80% | 3.04% | 5.69% | 20.36% | 32.40% | 81 440 |
| REGENERON PHARMACEUTICALS, INC. | -0.60% | 2.27% | 4.43% | 20.97% | 120.88% | 80 956 |
 | WUXI APPTEC CO., LTD. | 1.19% | -2.56% | 17.28% | -9.35% | 66.61% | 40 901 |
| BIONTECH SE | 0.71% | 0.22% | -4.09% | -20.03% | 375.95% | 34 764 |
| BEIGENE, LTD. | 0.60% | -3.50% | 16.30% | 4.15% | 65.55% | 26 436 |
 | GENMAB A/S | -2.03% | 0.87% | -11.46% | 12.82% | 64.86% | 25 500 |
 | ARGENX SE | -1.62% | -1.32% | -2.58% | 39.92% | 154.73% | 20 880 |
| SAREPTA THERAPEUTICS, INC. | -2.01% | -0.65% | -7.47% | 67.88% | 3.97% | 10 741 |
| NEUROCRINE BIOSCIENCES, INC. | -3.65% | 1.31% | -11.09% | 34.85% | 5.72% | 10 596 |
| LEGEND BIOTECH CORPORATION | 0.74% | -2.72% | 4.54% | 26.20% | --.--% | 8 671 |
| HALOZYME THERAPEUTICS, INC. | 0.23% | -0.61% | -8.10% | 49.36% | 172.20% | 7 054 |
| ASCENDIS PHARMA A/S | -3.25% | 3.00% | -2.16% | -0.82% | -14.68% | 6 916 |
| KARUNA THERAPEUTICS, INC. | -0.55% | -1.01% | -1.67% | 76.74% | 108.18% | 6 676 |
 | REMEGEN CO., LTD. | 5.19% | 0.61% | 20.73% | 38.42% | --.--% | 5 865 |
| EXELIXIS, INC. | 0.80% | 1.33% | 10.35% | -1.23% | 1.26% | 5 664 |
| | | | | | | |
| | Media | -0.54% | 0.02% | 2.05% | 24.02% | 89.05% | |
| | Media ponderata per Capi. | -1.07% | 0.64% | 3.78% | 15.94% | 102.59% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
